Parallax Volatility Advisers
SPPI

Parallax Volatility Advisers’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Parallax Volatility Advisers’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22
Closed – – 4309
2018
Q4 		$0 Buy
+22
New +$280 ﹤0.01% 4213
2018
Q1 		– Sell
-15,476
Closed -$293K – 4661
2017
Q4 		$293K Buy
+15,476
New +$280K ﹤0.01% 1957

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parallax Volatility Advisers's SPPI Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2019, closing a stake of 22 shares.

Parallax Volatility Advisers first reported a position in SPPI in Q4 2017 and held it in 2 quarters. The position peaked at $293K in Q4 2017. 173 funds tracked by Wall St. Rank hold SPPI as of Q1 2019.

  • Parallax Volatility Advisers reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 22 Spectrum Pharmaceuticals Inc shares in Q1 2019.
  • Parallax Volatility Advisers first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Spectrum Pharmaceuticals Inc position peaked at $293K in Q4 2017.
  • 173 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.